Citation 74715

PATIL,AD: KUMAR,NV: KOKKE,WC: BEAN,MF: FREYER,AJ: DE BROSSE,C: MAI,S: TRUNEH,A: FAULKNER,DJ: CARTE,B: BREEN,AL: HERTZBERG,RP: JOHNSON,RK: WESTLEY,JW: POTTS,BCM:. (1995). NOVEL ALKALOIDS FROM THE SPONGE BATZELLA SP.: INHIBITORS OF HIV GP120-HUMAN CD4 BINDING.. 60(5)

Citation Details

Title	NOVEL ALKALOIDS FROM THE SPONGE BATZELLA SP.: INHIBITORS OF HIV GP120-HUMAN CD4 BINDING.
Authors	PATIL,AD: KUMAR,NV: KOKKE,WC: BEAN,MF: FREYER,AJ: DE BROSSE,C: MAI,S: TRUNEH,A: FAULKNER,DJ: CARTE,B: BREEN,AL: HERTZBERG,RP: JOHNSON,RK: WESTLEY,JW: POTTS,BCM:
Year	1995
Volume	60
Issue	5

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Batzella species (ESPERIOPSIDAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	PTILOCAULIN	None
2	Not specified	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BATZELLADINE A	None
3	GP120 BINDING TO CD4+ CELLS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BATZELLADINE A	ACTIVE
4	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BATZELLADINE A	INACTIVE
5	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BATZELLADINE A	ACTIVE
6	INTERLEUKIN BINDING SITE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BATZELLADINE A	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BATZELLADINE A	ACTIVE
8	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BATZELLADINE B	None
9	GP120 BINDING TO CD4+ CELLS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BATZELLADINE B	ACTIVE
10	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BATZELLADINE B	INACTIVE
11	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	BATZELLADINE B	ACTIVE
12	INTERLEUKIN BINDING SITE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	BATZELLADINE B	ACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BATZELLADINE B	ACTIVE
14	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BATZELLADINE C	None
15	GP120 BINDING TO CD4+ CELLS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BATZELLADINE C	INACTIVE
16	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BATZELLADINE C	INACTIVE
17	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BATZELLADINE C	WEAK ACTIVITY
18	INTERLEUKIN BINDING SITE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BATZELLADINE C	WEAK ACTIVITY
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BATZELLADINE C	ACTIVE
20	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BATZELLADINE D	None
21	GP120 BINDING TO CD4+ CELLS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BATZELLADINE D	EQUIVOCAL
22	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BATZELLADINE D	INACTIVE
23	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BATZELLADINE D	WEAK ACTIVITY
24	INTERLEUKIN BINDING SITE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BATZELLADINE D	WEAK ACTIVITY
25	ALDOSTERONE ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BATZELLADINE D	ACTIVE
26	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BATZELLADINE E	None
27	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CRAMBESCIN A	None
28	GP120 BINDING TO CD4+ CELLS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CRAMBESCIN A	INACTIVE
29	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRAMBESCIN A	INACTIVE
30	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CRAMBESCIN A	WEAK ACTIVITY
31	INTERLEUKIN BINDING SITE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CRAMBESCIN A	INACTIVE
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CRAMBESCIN A	ACTIVE
33	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PTILOMYCALIN A	None
34	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CRAMBESCIDIN 800	None
35	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CRAMBESCIDIN 816	None

Citation 74715

Citation Details

Summary

Organisms and Their Experiments (1)

Batzella species (ESPERIOPSIDAE)

Show SPARQL Queries (1)

Query 1